Publications in DiVA – Anna Dimberg
-
CD93 maintains endothelial barrier function by limiting the phosphorylation and turnover of VE-cadherin
Part of The FASEB Journal, 2023.
DOI for CD93 maintains endothelial barrier function by limiting the phosphorylation and turnover of VE-cadherin Download full text (pdf) of CD93 maintains endothelial barrier function by limiting the phosphorylation and turnover of VE-cadherin
-
Complementarity-determining region clustering may cause CAR-T cell dysfunction
Part of Nature Communications, 2023.
DOI for Complementarity-determining region clustering may cause CAR-T cell dysfunction Download full text (pdf) of Complementarity-determining region clustering may cause CAR-T cell dysfunction
-
Dimerization of the C-type lectin-like receptor CD93 promotes its binding to Multimerin-2 in endothelial cells
Part of International Journal of Biological Macromolecules, p. 453-464, 2023.
DOI for Dimerization of the C-type lectin-like receptor CD93 promotes its binding to Multimerin-2 in endothelial cells Download full text (pdf) of Dimerization of the C-type lectin-like receptor CD93 promotes its binding to Multimerin-2 in endothelial cells
-
Editorial: The blood-brain barrier in brain tumors: molecular mechanisms and therapeutic strategies
Part of Frontiers in Neurology, 2023.
DOI for Editorial: The blood-brain barrier in brain tumors: molecular mechanisms and therapeutic strategies Download full text (pdf) of Editorial: The blood-brain barrier in brain tumors: molecular mechanisms and therapeutic strategies
-
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
Part of Cancer Cell, p. 1134-1151, 2023.
DOI for Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma Download full text (pdf) of Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
-
Tertiary Lymphoid Structures: From Basic Biology to Translational Impact in Cancer. Editorial
Part of Frontiers in Immunology, 2022.
DOI for Tertiary Lymphoid Structures: From Basic Biology to Translational Impact in Cancer. Editorial Download full text (pdf) of Tertiary Lymphoid Structures: From Basic Biology to Translational Impact in Cancer. Editorial
-
Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden
Part of Cancer Immunology and Immunotherapy, p. 2029-2040, 2022.
DOI for Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden Download full text (pdf) of Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden
-
1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas
Part of Cellular Oncology, p. 193-204, 2021.
-
Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma
Part of Nature Communications, 2021.
DOI for Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma Download full text (pdf) of Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma
-
CD93 Signaling via Rho Proteins Drives Cytoskeletal Remodeling in Spreading Endothelial Cells
Part of International Journal of Molecular Sciences, 2021.
DOI for CD93 Signaling via Rho Proteins Drives Cytoskeletal Remodeling in Spreading Endothelial Cells Download full text (pdf) of CD93 Signaling via Rho Proteins Drives Cytoskeletal Remodeling in Spreading Endothelial Cells
-
Deletions on Chromosome Y and Downregulation of the SRY Gene in Tumor Tissue Are Associated with Worse Survival of Glioblastoma Patients
Part of Cancers, 2021.
DOI for Deletions on Chromosome Y and Downregulation of the SRY Gene in Tumor Tissue Are Associated with Worse Survival of Glioblastoma Patients Download full text (pdf) of Deletions on Chromosome Y and Downregulation of the SRY Gene in Tumor Tissue Are Associated with Worse Survival of Glioblastoma Patients
-
ELTD1-deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.
Part of Neuro-Oncology, p. 398-411, 2021.
DOI for ELTD1-deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma. Download full text (pdf) of ELTD1-deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.
-
IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma
Part of MOLECULAR THERAPY-ONCOLYTICS, p. 37-46, 2021.
DOI for IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma Download full text (pdf) of IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma
-
Key molecular alterations in endothelial cells in human glioblastoma uncovered through single-cell RNA sequencing
Part of JCI Insight, 2021.
DOI for Key molecular alterations in endothelial cells in human glioblastoma uncovered through single-cell RNA sequencing Download full text (pdf) of Key molecular alterations in endothelial cells in human glioblastoma uncovered through single-cell RNA sequencing
-
Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis
Part of Cancer Research, p. 3345-3358, 2020.
DOI for Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis
-
The Binding of CD93 to Multimerin-2 Promotes Choroidal Neovascularization
Part of Investigative Ophthalmology and Visual Science, 2020.
DOI for The Binding of CD93 to Multimerin-2 Promotes Choroidal Neovascularization Download full text (pdf) of The Binding of CD93 to Multimerin-2 Promotes Choroidal Neovascularization
-
Tumor angiogenesis: causes, consequences, challenges and opportunities
Part of Cellular and Molecular Life Sciences (CMLS), p. 1745-1770, 2020.
DOI for Tumor angiogenesis: causes, consequences, challenges and opportunities Download full text (pdf) of Tumor angiogenesis: causes, consequences, challenges and opportunities
-
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
Part of Oncoimmunology, 2020.
DOI for Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy Download full text (pdf) of Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
-
Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
Part of BMC Cancer, 2020.
DOI for Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib Download full text (pdf) of Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
-
Coagulation Factor Xa Promotes Solid Tumor Growth, Experimental Metastasis and Endothelial Cell Activation
Part of Cancers, 2019.
DOI for Coagulation Factor Xa Promotes Solid Tumor Growth, Experimental Metastasis and Endothelial Cell Activation Download full text (pdf) of Coagulation Factor Xa Promotes Solid Tumor Growth, Experimental Metastasis and Endothelial Cell Activation
-
Region-by-region analysis of PET, MRI, and histology in en bloc-resected oligodendrogliomas reveals intra-tumoral heterogeneity
Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 569-579, 2019.
-
The small GTPase Rab5c is a key regulator of trafficking of the CD93/Multimerin-2/1 integrin complex in endothelial cell adhesion and migration
Part of Cell Communication and Signaling, 2019.
DOI for The small GTPase Rab5c is a key regulator of trafficking of the CD93/Multimerin-2/1 integrin complex in endothelial cell adhesion and migration Download full text (pdf) of The small GTPase Rab5c is a key regulator of trafficking of the CD93/Multimerin-2/1 integrin complex in endothelial cell adhesion and migration
-
Bones in human CYP26B1 deficiency and rats with hypervitaminosis A phenocopy Vegfa overexpression
Part of Bone Reports, p. 27-36, 2018.
DOI for Bones in human CYP26B1 deficiency and rats with hypervitaminosis A phenocopy Vegfa overexpression Download full text (pdf) of Bones in human CYP26B1 deficiency and rats with hypervitaminosis A phenocopy Vegfa overexpression
-
CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis
Part of Journal of Clinical Investigation, p. 3280-3297, 2018.
DOI for CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis Download full text (pdf) of CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis
-
Consensus guidelines for the use and interpretation of angiogenesis assays
Part of Angiogenesis, p. 425-532, 2018.
DOI for Consensus guidelines for the use and interpretation of angiogenesis assays Download full text (pdf) of Consensus guidelines for the use and interpretation of angiogenesis assays
-
IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas
Part of Neuro-Oncology, p. 1505-1516, 2018.
DOI for IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas Download full text (pdf) of IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas
-
Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
Part of Frontiers in Immunology, 2018.
DOI for Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer Download full text (pdf) of Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
-
Activating CD40 While Inhibiting IL6R Induces Cytokine Production without PDL1 Upregulation in DCs
Part of Molecular Therapy, p. 54-54, 2017.
-
Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment
Part of Gene Therapy, p. 92-103, 2017.
DOI for Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment Download full text (pdf) of Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment
-
Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer
Part of European Journal of Immunology, p. 385-393, 2017.
-
Safe and effective treatment of experimental neuroblastoma and glioblastoma using systemically administered triple microRNA-detargeted oncolytic Semliki Forest virus
Part of Clinical Cancer Research, p. 1519-1530, 2017.
-
Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus.
Part of Clinical Cancer Research, p. 5846-5857, 2017.
-
The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells
Part of Seminars in Cancer Biology, p. 23-35, 2017.
DOI for The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells Download full text (pdf) of The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells
-
ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
Part of BMC Cancer, 2016.
DOI for ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer Download full text (pdf) of ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
-
Heparanase Promotes Glioma Progression and is Inversely Correlated with Patient Survival.
Part of Molecular Cancer Research, p. 1243-1253, 2016.
DOI for Heparanase Promotes Glioma Progression and is Inversely Correlated with Patient Survival.
-
Pleiotrophin enhances PDGFB-induced gliomagenesis through increased proliferation of neural progenitor cells
Part of OncoTarget, p. 80382-80390, 2016.
DOI for Pleiotrophin enhances PDGFB-induced gliomagenesis through increased proliferation of neural progenitor cells Download full text (pdf) of Pleiotrophin enhances PDGFB-induced gliomagenesis through increased proliferation of neural progenitor cells
-
Pleiotrophin is a driver of vascular abnormalization in glioblastoma
Part of Molecular & Cellular Oncology, 2016.
DOI for Pleiotrophin is a driver of vascular abnormalization in glioblastoma
-
Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment
Part of OncoTarget, p. 50277-50289, 2016.
DOI for Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment Download full text (pdf) of Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment
-
Elevated Expression of the C-Type Lectin CD93 in the Glioblastoma Vasculature Regulates Cytoskeletal Rearrangements That Enhance Vessel Function and Reduce Host Survival
Part of Cancer Research, p. 4504-4516, 2015.
-
Neutrophil Extracellular Traps Accumulate in Peripheral Blood Vessels and Compromise Organ Function in Tumor-Bearing Animals
Part of Cancer Research, p. 2653-2662, 2015.
-
Next-Generation Pathology: Surveillance of Tumor Microecology
Part of Journal of Molecular Biology, p. 2013-2022, 2015.
DOI for Next-Generation Pathology: Surveillance of Tumor Microecology
-
VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-κB-induced endothelial activation
Part of The FASEB Journal, p. 227-238, 2015.
-
Progression of metastatic breast cancer can be attenuated by therapeutic vaccination against the tumor vascular marker ED-A
Part of Angiogenesis, p. 769-769, 2014.
-
The glioblastoma vasculature as a target for cancer therapy
Part of Biochemical Society Transactions, p. 1647-1652, 2014.
DOI for The glioblastoma vasculature as a target for cancer therapy
-
alpha B-crystallin/HspB5 regulates endothelial-leukocyte interactions by enhancing NF-kappa B-induced up-regulation of adhesion molecules ICAM-1, VCAM-1 and E-selectin
Part of Angiogenesis, p. 975-983, 2013.
DOI for alpha B-crystallin/HspB5 regulates endothelial-leukocyte interactions by enhancing NF-kappa B-induced up-regulation of adhesion molecules ICAM-1, VCAM-1 and E-selectin Download full text (pdf) of alpha B-crystallin/HspB5 regulates endothelial-leukocyte interactions by enhancing NF-kappa B-induced up-regulation of adhesion molecules ICAM-1, VCAM-1 and E-selectin
-
GABA-A Channel Subunit Expression in Human Glioma Correlates with Tumor Histology and Clinical Outcome
Part of PLOS ONE, p. e37041-, 2012.
DOI for GABA-A Channel Subunit Expression in Human Glioma Correlates with Tumor Histology and Clinical Outcome Download full text (pdf) of GABA-A Channel Subunit Expression in Human Glioma Correlates with Tumor Histology and Clinical Outcome
-
Paladin (X99384) is expressed in the vasculature and shifts from endothelial to vascular smooth muscle cells during mouse development
Part of Developmental Dynamics, p. 770-786, 2012.
-
Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma
Part of BMC Cancer, p. 318-, 2012.
DOI for Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma Download full text (pdf) of Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma
-
Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization
Part of Journal of Pathology, p. 378-390, 2012.
-
Vascular endothelial growth factor receptor 2 (VEGFR-2) signalling activity in paediatric pilocytic astrocytoma is restricted to tumour endothelial cells
Part of Neuropathology and Applied Neurobiology, p. 538-548, 2011.
-
Chemokines in Angiogenesis
Part of Current Topics in Microbiology and Immunology, p. 59-80, 2010.
-
Activated platelets provide a functional microenvironment for the antiangiogenic fragment of histidine-rich glycoprotein
Part of Molecular Cancer Research, p. 1792-1802, 2009.
-
Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis
Part of The FASEB Journal, p. 1490-1502, 2009.
-
Ninein Is Expressed in the Cytoplasm of Angiogenic Tip-Cells and Regulates Tubular Morphogenesis of Endothelial Cells
Part of Arteriosclerosis, Thrombosis and Vascular Biology, p. 2123-2130, 2008.
-
Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer
Part of Experimental Cell Research, p. 1285-1294, 2007.
DOI for Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer
-
IFN-gamma-induced upregulation of Fc gamma-receptor-I during activation of monocytic cells requires the PKR and NF kappa B pathways
Part of Molecular Immunology, p. 615-624, 2007.
-
Lentiviral rescue of vascular endothelial growth factor receptor-2 expression in flk1-/- embryonic stem cells shows early priming of endothelial precursors
Part of Stem Cells, p. 2987-2995, 2007.
-
Inhibition of monocytic differentiation by phosphorylation-deficient Stat1 is associated with impaired expression of Stat2, ICSBP/IRF8 and C/EBP epsilon
Part of Scandinavian Journal of Immunology, p. 271-279, 2006.
-
VEGF receptor signalling: in control of vascular function
Part of Nature reviews. Molecular cell biology, p. 359-371, 2006.
DOI for VEGF receptor signalling: in control of vascular function
-
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development
Part of Arteriosclerosis, Thrombosis and Vascular Biology, p. 944-949, 2005.
-
VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis.
Part of EMBO J, p. 2342-53, 2005.
-
Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone.
Part of Blood, p. 3138-47, 2004.
-
Retinoic acid-induced cell cycle arrest of human myeloid cell lines.
Part of Leuk Lymphoma, p. 1641-, 2003.
-
Phosphorylation-deficient Stat1 inhibits retinoic acid-induceddifferentiation and cell cycle arrest in U-937 monoblasts.
Part of Blood, p. 2870-, 2000.
-
Stat1 involvement in retinoic acid induced differentiation of myeloid cells
Part of Molecular mechanisms of signal transduction, p. 211-, 2000.